Investors seeking the highest returns, invest in early-stage & post seed cannabis companies.

• Round two open for subscriptions at 15p per share, £2m initial raise
• Pharmaceutical acquisition made in Germany, largest EU market
• Ethical investment for the treatments of Epilepsy, MS, Cancer and ADHD
• 3 year joint venture with Charite University Hospital Berlin
• Planned IPO first quarter 2023 on major exchange

Disclaimer: Any person accessing the email and considering potential investment opportunities featured on the email should make their own commercial assessment of an investment opportunity after seeking the advice of an appropriately authorised or regulated financial advisor. This email should not be construed as advice or a personal recommendation to any prospective investor.